Table II.
Parameters and Likelihood of Dose‐Response Models Fitted to Data Sets on Coronavirus Infection
No. | Virus | Host | Beta‐Poisson(BP) | Exponential (EXP) | Better Fit Model** | Unit of Dose | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Species | Age | ln α | ln N 50 | Deviance | P fit | ln k | Deviance | P fit | ||||
1 | rSARS‐CoV | tgMice | ? | ‐* | ‐ | ‐ | ‐ | 5.82 | 0.97 | 0.81 | PFU | |
2 | MHV‐1 | Mice | 6 to 8 weeks | 1.23 | 5.71 | 0.54 | 0.76 | 6.15 | 0.61 | 0.89 | EXP | PFU |
p† | SARS‐CoV | Mice | ? | 6.50 | 5.64 | 1.75 | 0.94 | 6.01 | 1.75 | 0.97 | EXP | PFU |
3 | HCoV‐229E | Humans | 18 to 50 years | −0.21 | 2.38 | 1.42 | 0.49 | 2.92 | 2.31 | 0.51 | EXP | TCD50 |
4 | MHV‐S | Mice | 3 days | ‐ | ‐ | ‐ | ‐ | 6.32 | 0.56 | 0.91 | PFU | |
5 | MHV‐S | Mice | 1 week | ‐ | ‐ | ‐ | ‐ | 8.62 | 0.56 | 0.91 | PFU | |
6 | MHV‐S | Mice | 2 weeks | ‐ | ‐ | ‐ | ‐ | 13.6 | 0.24 | 0.97 | PFU | |
7 | MHV‐2 | Mice | 3 weeks | (No death among 5 mice at doses from 7 × 102 to 7 × 104) | PFU | |||||||
8 | MHV‐2 | Mice | 4 weeks | (No death among 5 mice at doses from 6 × 103 to 6 × 105) | PFU | |||||||
9 | HEV‐67N | Mice | 1 week | ‐ | ‐ | ‐ | ‐ | 2.39 | 0†† | PFU | ||
10 | HEV‐67N | Mice | 4 weeks | ‐ | ‐ | ‐ | ‐ | 7.62 | 0.62 | 0.96 | PFU | |
11 | HEV‐67N | Mice | 8 weeks | ‐ | ‐ | ‐ | ‐ | 7.62 | 0.62 | 0.96 | PFU | |
12 | HEV‐67N | Rats | 1 week | ‐ | ‐ | ‐ | ‐ | 3.08 | 0†† | PFU | ||
13 | HEV‐67N | Rats | 4 weeks | ‐ | ‐ | ‐ | ‐ | 8.66 | 0.54 | 0.76 | PFU | |
14 | HEV‐67N | Rats | 8 weeks | −1.04 | 7.42 | 1.97 | 0.16 | 9.34 | 6.36 | 0.04 | BP | PFU |
15 | IBVA‐5968 | Chicks | 9 weeks | −5.11 | 109 | 2.93 | 0.57 | 11.4 | 26.6 | <0.01 | BP | CD50 |
*Beta‐Poisson model was not fitted to data sets including less than two dose points corresponding to other than 0 or 100% response.
**Beta‐Poisson model was employed if it provided a significant improvement of fit (p > 0.05) rather than exponential model.
†Data set p pooled data sets 1 and 2.
††Zero deviance means that all data were on the model.